SCHEMBL30075813

SCHEMBL30075813

CCCCOC(=O)N1CC(S(=O)(=O)CC2CNC2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ATM Q13315 1/20 0.34
▸ CHRNB2 P17787 4/20 0.34
▸ CHRNA4 P43681 4/20 0.34
▸ CHRNB4 P30926 2/20 0.34
▸ CHRNA3 P32297 2/20 0.34
▸ GBA2 Q9HCG7 1/20 0.34
▸ HRH2 P25021 1/20 0.33
▸ HRH1 P35367 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CHRM2 P08172 1/20 0.32
▸ CHRM1 P11229 1/20 0.32
▸ P2RY12 Q9H244 2/20 0.32
▸ CHRNA7 P36544 1/20 0.31
▸ HCAR2 Q8TDS4 1/20 0.31
▸ MMP3 P08254 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16994014 0.78 CHRNA4 (0.57) LMNAPOLBSMN1; SMN2ATMCHRNB2
SCHEMBL23578950 0.77 NR1H2 (0.47) SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL23578989 0.74 CHRNB2 (0.33) CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7
SCHEMBL27028419 0.72 LMNA (0.51) LMNAPOLBSMN1; SMN2ATMHRH2
SCHEMBL4968757 0.71 LMNA (0.53) LMNAPOLBSMN1; SMN2ATMCHRNB2
SCHEMBL4968751 0.71 LMNA (0.53) LMNAPOLBSMN1; SMN2ATMCHRNB2
SCHEMBL3652718 0.71 LMNA (0.56) LMNAPOLBSMN1; SMN2ATMCHRNB2
SCHEMBL1633241 0.71 LMNA (0.56) LMNAPOLBSMN1; SMN2ATMCHRNB2
SCHEMBL20912047 0.71 POLB (0.56) LMNAPOLBSMN1; SMN2ATMCHRNB2
SCHEMBL18498621 0.71 LMNA (0.56) LMNAPOLBSMN1; SMN2ATMCHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081515-A1 INHIBITORS OF MUTANT FORMS OF EGFR Blueprint Medicines Corporation (US) 2022-11-02 — — EP disclosed
Send feedback